Intl Stem Cell completes sale of unit Lifeline Cell to ATCC for $25.25M
International Stem Cell Corp sold its subsidiary LCT to ATCC for $25.25 million. The unaudited pro forma financials indicate a substantial increase in assets, specifically cash and cash equivalents.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day